Literature DB >> 7504160

Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse.

R D'Amato1, E Wesolowski, L E Smith.   

Abstract

Methods currently available for the examination of the retinal vasculature of laboratory animals have significant drawbacks. Fluorescein angiography of rodent eyes is hampered by a poor view of the peripheral retina and difficulty in performing fundus photography. Methods of staining or filling retinal vessels are unreliable, labor-intensive, or have high backgrounds. We have developed a novel technique that is quick, simple, and accurate. Fluorescein-labeled 2 million molecular weight dextrans are used to fill the retinal vasculature of mice in vivo, followed by removal of the retina, fixation in paraformaldehyde, and examination of the vascular pattern in whole mount preparations by fluorescence microscopy. We found that fluorescein and fluorescein-labeled low-molecular-weight dextrans (40,000-500,000) are not suitable as they leak out of the vasculature to stain the entire retina in whole mount preparations. By contrast, fluorescein-labeled 2 million molecular weight dextrans remain in the vasculature for many months without diffusion or decay. Under low magnification, the entire retinal vasculature can be visualized at one time. By focusing from one plane to another, the superficial, connecting, or deep vascular layers are delineated. The background fluorescence is very low. We have successfully used this technique in over 20 mice per day to document retinal angiogenesis in a model of oxygen-induced proliferative retinopathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504160     DOI: 10.1006/mvre.1993.1042

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  34 in total

Review 1.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

2.  Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy.

Authors:  Naomi Chadderton; Sophia Millington-Ward; Arpad Palfi; Mary O'Reilly; Gearóid Tuohy; Marian M Humphries; Tiansen Li; Peter Humphries; Paul F Kenna; G Jane Farrar
Journal:  Mol Ther       Date:  2009-01-27       Impact factor: 11.454

3.  Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease.

Authors:  Ophélie Vacca; Brahim El Mathari; Marie Darche; José-Alain Sahel; Alvaro Rendon; Deniz Dalkara
Journal:  J Vis Exp       Date:  2015-04-19       Impact factor: 1.355

4.  Proteolytic Degradation and Inflammation Play Critical Roles in Polypoidal Choroidal Vasculopathy.

Authors:  Sandeep Kumar; Hiroyuki Nakashizuka; Alex Jones; Alyssia Lambert; Xuchen Zhao; Megan Shen; Mackenzie Parker; Shixian Wang; Zachary Berriochoa; Amrita Fnu; Stephanie VanBeuge; Patricia Chévez-Barrios; Mark Tso; Jon Rainier; Yingbin Fu
Journal:  Am J Pathol       Date:  2017-09-21       Impact factor: 4.307

5.  Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice.

Authors:  Philip Maier; Anke S Unsoeld; Bernd Junker; Gottfried Martin; Joachim Drevs; Lutz L Hansen; Hansjürgen T Agostini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-01-14       Impact factor: 3.117

6.  Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.

Authors:  Shu-Ching Shih; Meihua Ju; Nan Liu; Lois E H Smith
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo.

Authors:  Shu-Ching Shih; Meihua Ju; Nan Liu; Jan-Rung Mo; Joshua J Ney; Lois E H Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-03       Impact factor: 11.205

8.  The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity.

Authors:  Ronen Rabinowitz; Gabriel Katz; Mordechai Rosner; Sara Pri-Chen; Abraham Spierer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-03-15       Impact factor: 3.117

9.  Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.

Authors:  Katsuhiro Miyajima; Susumu Takekoshi; Johbu Itoh; Kochi Kakimoto; Takashi Miyakoshi; Robert Yoshiyuki Osamura
Journal:  Acta Histochem Cytochem       Date:  2010-04-07       Impact factor: 1.938

10.  Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization.

Authors:  Brian J Raisler; Kenneth I Berns; Maria B Grant; Denis Beliaev; William W Hauswirth
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.